{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:47:02Z","timestamp":1779911222830,"version":"3.53.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.ejps.2010.10.001","type":"journal-article","created":{"date-parts":[[2010,10,17]],"date-time":"2010-10-17T08:27:12Z","timestamp":1287304032000},"page":"19-29","source":"Crossref","is-referenced-by-count":10,"title":["Transport of 5,5-diphenylbarbituric acid and its precursors and their effect on P-gp, MRP2 and CYP3A4 in Caco-2 and LS180 cells"],"prefix":"10.1016","volume":"42","author":[{"given":"J.","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-J.","family":"Maeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.S.","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2010.10.001_bib0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1210\/me.2003-0244","article-title":"Structural determinants for vitamin D receptor response to endocrine and xenobiotic signals","volume":"18","author":"Adachi","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejps.2010.10.001_bib0010","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0006-291X(91)91647-U","article-title":"Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells","volume":"175","author":"Artursson","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejps.2010.10.001_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0169-409X(00)00128-9","article-title":"Caco-2 monolayers in experimental and theoretical predictions of drug transport","volume":"46","author":"Artursson","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2010.10.001_bib0020","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/mp0600687","article-title":"Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine","volume":"4","author":"Berggren","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2010.10.001_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.09.005","article-title":"Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX)","volume":"83","author":"Bialer","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejps.2010.10.001_bib0030","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1515\/BC.2005.060","article-title":"A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression","volume":"386","author":"Burk","year":"2005","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejps.2010.10.001_bib0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1124\/jpet.300.1.97","article-title":"Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats","volume":"300","author":"Cherrington","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2010.10.001_bib0040","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bcp.2004.05.006","article-title":"Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions?","volume":"68","author":"Collett","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2010.10.001_bib0045","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0014-5793(99)01295-8","article-title":"Up-regulation of multidrug resistance-associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone","volume":"459","author":"Courtois","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejps.2010.10.001_bib0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/10611860600720814","article-title":"Limited P-glycoprotein mediated efflux for anti-epileptic drugs","volume":"14","author":"Crowe","year":"2006","journal-title":"J. Drug Target"},{"key":"10.1016\/j.ejps.2010.10.001_bib0055","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2174\/138161208784746798","article-title":"Clinical drugs that interact with St. John's wort and implication in drug development","volume":"14","author":"Di","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejps.2010.10.001_bib0060","doi-asserted-by":"crossref","first-page":"33309","DOI":"10.1074\/jbc.C100375200","article-title":"Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor SXR","volume":"276","author":"Dussault","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2010.10.001_bib0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/jpet.108.149815","article-title":"Up-regulation of transporters and enzymes by the vitamin D receptor ligands, 1\u03b1,25-dihydroxyvitamin D3 and vitamin D analogs, in the Caco-2 cell monolayer","volume":"330","author":"Fan","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2010.10.001_bib0070","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1016\/S0021-9258(18)82061-0","article-title":"Selective induction by phenobarbital of the electrogenic transport of glutathione and organic anions in rat liver canalicular membrane vesicles","volume":"268","author":"Fernandez-Checa","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2010.10.001_bib0075","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0002-9440(10)64794-3","article-title":"The effect of rifampin treatment on intestinal expression of human MRP transporters","volume":"157","author":"Fromm","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejps.2010.10.001_bib0080","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1124\/mol.56.6.1329","article-title":"The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module","volume":"56","author":"Goodwin","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejps.2010.10.001_bib0085","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1124\/dmd.107.018689","volume":"36","author":"Gupta","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2010.10.001_bib0090","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1248\/bpb.29.1032","article-title":"Expression and regulation of breast cancer resistance protein and multidrug resistance associated protein 2 in BALB\/c mice","volume":"29","author":"Han","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejps.2010.10.001_bib0095","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/mol.109.061754","article-title":"Restoring blood\u2013brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease","volume":"77","author":"Hartz","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejps.2010.10.001_bib0100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-3565(24)29384-8","article-title":"P-glycoprotein-mediated efflux of indinavir metabolites in Caco-2 cells expressing cytochrome P450 3A4","volume":"298","author":"Hochman","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2010.10.001_bib0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1517\/17425255.2.3.351","article-title":"Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition","volume":"2","author":"Jedlitschky","year":"2006","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejps.2010.10.001_bib0110","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1074\/jbc.M109326200","article-title":"Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor","volume":"277","author":"Kast","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2010.10.001_bib0115","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s002040050571","article-title":"Induction of hepatic Mrp2 (cmrp\/cmoat) gene expression in nonhuman primates treated with rifampicin or tamoxifen","volume":"72","author":"Kauffmann","year":"1998","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejps.2010.10.001_bib0120","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0090-9556(24)15238-5","article-title":"The use of human hepatocyte cultures to study the induction of cytochrome P-450","volume":"27","author":"Kostrubsky","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2010.10.001_bib0125","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.0013-9580.2004.12704.x","article-title":"Phenobarbital for the treatment of epilepsy in the 21st century: a critical review","volume":"45","author":"Kwan","year":"2004","journal-title":"Epilepsia"},{"issue":"Suppl. 5","key":"10.1016\/j.ejps.2010.10.001_bib0130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1528-1167.2007.01302.x","article-title":"ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy","volume":"48","author":"Lazarowski","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2010.10.001_bib0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0939-6411(00)00091-6","article-title":"Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards","volume":"50","author":"Lobenberg","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2010.10.001_bib0140","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1528-1167.2006.00607.x","article-title":"Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs","volume":"47","author":"Loscher","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2010.10.001_bib0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2010.10.001_bib0150","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1124\/mol.62.3.638","article-title":"Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification","volume":"62","author":"Maglich","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejps.2010.10.001_bib0155","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/jpet.102.039255","article-title":"Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs","volume":"303","author":"Mahar Doan","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2010.10.001_bib0160","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.bjp.0707601","article-title":"Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells","volume":"153","author":"Martin","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2010.10.001_bib0165","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0306-4522(93)90527-M","article-title":"Aluminum silicate toxicity in cell cultures","volume":"55","author":"Murphy","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejps.2010.10.001_bib0170","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-2005-837780","article-title":"Inhibitory activity of a green tea extract and some of its constituents on multidrug resistance-associated protein 2 functionality","volume":"71","author":"Netsch","year":"2005","journal-title":"Planta Med."},{"key":"10.1016\/j.ejps.2010.10.001_bib0175","first-page":"M1331","article-title":"Drug interaction assessment of T2000 and its major metabolites in human liver microsomes and primary human hepatocytes in culture","author":"Nguyen","year":"2006","journal-title":"AAPS Abstr."},{"key":"10.1016\/j.ejps.2010.10.001_bib0180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/jpet.108.149690","article-title":"Pregnane X receptor (PXR) regulates P-glycoprotein at the blood-brain barrier: functional similarities between pig and human PXR","volume":"329","author":"Ott","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2010.10.001_bib0185","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1124\/dmd.31.12.1507","article-title":"Modeling of intestinal drug absorption: roles of transporters and metabolic enzymes (for the Gillette Review Series)","volume":"31","author":"Pang","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2010.10.001_bib0190","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1124\/mol.64.1.154","article-title":"Phenobarbital alters hepatic Mrp2 function by direct and indirect interactions","volume":"64","author":"Patel","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejps.2010.10.001_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2008.09.014","article-title":"Exploring the possible interaction between anti-epilepsy drugs and multidrug efflux pumps; in vitro observations","volume":"598","author":"Rivers","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2010.10.001_bib0200","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2009.09.014","article-title":"Induction of intestinal multidrug resistance-associated protein 2 (Mrp2) by spironolactone in rats","volume":"623","author":"Ruiz","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2010.10.001_bib0205","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1528-1167.2005.54904.x","article-title":"Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms","volume":"46","author":"Schmidt","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2010.10.001_bib0210","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/17425255.4.4.395","article-title":"The Caco-2 cell monolayer: usefulness and limitations","volume":"4","author":"Sun","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejps.2010.10.001_bib0215","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/0091270007299930","article-title":"Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs","volume":"47","author":"Urquhart","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2010.10.001_bib0220","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2165\/00003088-200342150-00003","article-title":"Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes","volume":"42","author":"Wang","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2010.10.001_bib0225","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1126\/science.1060762","article-title":"The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity","volume":"292","author":"Watkins","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ejps.2010.10.001_bib0230","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF02977789","article-title":"Induction of phase I, II and III drug metabolism\/transport by xenobiotics","volume":"28","author":"Xu","year":"2005","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejps.2010.10.001_bib0235","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.clinthera.2008.08.011","article-title":"Drug interactions between chemotherapeutic regimens and antiepileptics","volume":"30","author":"Yap","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejps.2010.10.001_bib0240","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1528-1157.1985.tb05400.x","article-title":"Diphenylbarbituric acid: its effects on neuromuscular and spinal cord function in the cat","volume":"26","author":"Zavadil","year":"1985","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2010.10.001_bib0255","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1194\/jlr.M800608-JLR200","article-title":"Activation of PXR induces hypercholesterolemia in wild-type and accelerates atherosclerosis in apoE deficient mice","volume":"50","author":"Zhou","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejps.2010.10.001_bib0245","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/138920008784220664","article-title":"Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4","volume":"9","author":"Zhou","year":"2008","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ejps.2010.10.001_bib0250","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.drudis.2007.06.004","article-title":"Identification of drugs that interact with herbs in drug development","volume":"12","author":"Zhou","year":"2007","journal-title":"Drug Discov. Today"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098710003465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098710003465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T21:25:21Z","timestamp":1740605121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098710003465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":51,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0928098710003465"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2010.10.001","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}